483
Emcure Pharmaceuticals LimitedEmcure Pharmaceuticals Limited – FDA 483, May 15, 2026
Record Details
An FDA inspection of Emcure Pharmaceuticals Limited in Ahmedabad, India, revealed significant deficiencies in their drug manufacturing operations. The firm failed to adequately qualify equipment, thoroughly investigate product complaints, and maintain proper laboratory controls for raw materials. Critical issues were also identified in aseptic processing validation and contamination prevention for sterile drug products, alongside inadequate controls over computer systems and data integrity.
View Company Profile
ID · 08b85a58-35a5-4c21-8416-c2eeed65d6c2
Other documents for Emcure Pharmaceuticals Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.